Education
About Us
Working with TipRanks
Follow Us
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
Summary of all the Indicators
Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is -0.80, suggesting Jagsonpal Pharmaceuticals Ltd. is a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 226.22, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹220.1, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 225.36, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹220.1, making it a Sell.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points
Classic
198.33
205.87
209.93
217.47
221.53
229.07
233.13
Fibonacci
205.87
210.30
213.04
217.47
221.90
224.64
229.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages
MA5
221.62Sell
220.42Sell
MA10
227.91Sell
224.59Sell
MA20
230.04Sell
226.22Sell
MA50
224.65Sell
225.36Sell
MA100
224.88Sell
223.41Sell
MA200
220.59Sell
210.58Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 224.59, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹220.1, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 223.41, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹220.1, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹220.1 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 224.65, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹220.1 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 224.88, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹220.1 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 220.59, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators
RSI (14)
40.24
Neutral
STOCH (9,6)
7.45
Buy
STOCHRSI (14)
7.07
Buy
MACD (12,26)
-0.80
Buy
ADX (14)
16.22
Buy
Williams %R
-87.10
Buy
CCI (14)
-208.67
Buy
ATR (14)
10.40
-
Ultimate Oscillator
34.66
Neutral
ROC
-9.44
Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 40.24, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 16.22, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is -208.67, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is -9.44, creating a Sell signal.
FAQ
Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Sell.
What is JAGSNPHARM’s RSI (14)?
JAGSNPHARM’s RSI (14) is 40.24, which suggests JAGSNPHARM is a Neutral.
What is JAGSNPHARM’s MACD?
JAGSNPHARM’s MACD is -0.80, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s 5-day moving average?
JAGSNPHARM’s 5-day moving average is 221.62, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 20-day moving average?
JAGSNPHARM 20-day moving average is 230.04, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 50-day moving average?
JAGSNPHARM’s 50-day moving average is 224.65, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s 200-day moving average?
JAGSNPHARM’s 200-day moving average is 220.59, which suggests JAGSNPHARM is a Sell.
What is JAGSNPHARM’s Williams % R (14)?
JAGSNPHARM’s Williams % R (14) is -87.10, which suggests JAGSNPHARM is a Buy.
What is JAGSNPHARM’s CCI (14)?
JAGSNPHARM’s CCI (14) is -208.67, which suggests JAGSNPHARM is a Buy.
What is the share price of Jagsonpal Pharmaceuticals Ltd.?